Resistant tumor cells destroyed by combining cell replication blocker with common can

[News]

Researchers from the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter, have found that an agent that inhibits mitochondrial division can overcome tumor cell resistance to a commonly used cancer drug, and that the combination of the two induces rapid and synergistic cell death. Separately, neither had an effect.

More... (http://www.medicalnewstoday.com/releases/275126.php)